BiotechTube
Home/Inhibikase Therapeutics/Mark Iwicki
MI

Mark Iwicki

Chief Executive Officer

Inhibikase Therapeutics

Roles

Chief Executive OfficeratInhibikase Therapeutics
Chairman, President and Chief Executive OfficeratKala Pharmaceuticals

Therapeutic Areas

Cardiopulmonary DiseasePulmonary Arterial Hypertension

Inhibikase Therapeutics Pipeline

DrugIndicationPhase
IkT-001Pulmonary Arterial Hypertension (PAH)Phase 2

Leadership Team at Inhibikase Therapeutics

DM
David McIntyre
Chief Financial Officer
CC
Chris Cabell
President, Head of Research & Development, Chief Medical Officer
JA
John Adams
Chief Scientific Officer
VA
Vince Aurentz
Director
RB
Roberto Bellini
Director
DB
Dennis Berman
Director
DC
David Canner
Director
View full Inhibikase Therapeutics profile